Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers

This publication has 18 references indexed in Scilit:

• CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.
  The Journal of Experimental Medicine, 1996
• Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer
  International Journal of Cancer, 1996
• Vitamin D3 treatment of tumor bearers can stimulate immune competence and reduce tumor growth when treatment coincides with a heightened presence of natural suppressor cells
  Cancer Letters, 1996
• Immune modulation by interleukin-12 in tumor-bearing mice receiving vitamin D 3 treatments to block induction of immunosuppressive granulocyte/macrophage progenitor cells
  Cancer Immunology, Immunotherapy, 1996
• In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy
  The Prostate, 1995
• Effect of murine interferon ?/? on tumor-induced suppressor function
  Cancer Immunology, Immunotherapy, 1994
• THE INHIBITORY EFFECT OF CYCLOPHOSPHAMIDE-INDUCED MAC-1+ NATURAL SUPPRESSOR CELLS ON IL-2 AND IL-4 UTILIZATION IN MLR
  Transplantation, 1994
• Interleukins and Contrasuppression Induce Immune Regression of Head and Neck Cancer
  JAMA Otolaryngology–Head & Neck Surgery, 1994
• Tumour Growth Causes Suppression of Autoreactive T-Cell Proliferation by Disrupting Macrophage Responsiveness to Interferon-gamma
  Scandinavian Journal of Immunology, 1994
• Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide
  Cancer Immunology, Immunotherapy, 1992